XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022   20,244        
Beginning balance at Dec. 31, 2022 $ 145,066 $ 206 $ (5,017) $ 433,586 $ (281,226) $ (2,483)
Stock issued upon option exercise and vesting of restricted stock units (in shares)   375        
Stock issued upon option exercise and vesting of restricted and performance stock units 1,988 $ 4   1,984    
Share based compensation 1,337     1,337    
Net loss 339       339  
Other comprehensive loss 481         481
Ending balance (in shares) at Mar. 31, 2023   20,619        
Ending balance at Mar. 31, 2023 149,211 $ 210 (5,017) 436,907 (280,887) (2,002)
Beginning balance (in shares) at Dec. 31, 2022   20,244        
Beginning balance at Dec. 31, 2022 $ 145,066 $ 206 (5,017) 433,586 (281,226) (2,483)
Stock issued upon option exercise and vesting of restricted stock units (in shares) 283          
Net loss $ (3,426)          
Ending balance (in shares) at Jun. 30, 2023   20,705        
Ending balance at Jun. 30, 2023 146,814 $ 211 (5,017) 438,767 (284,652) (2,495)
Beginning balance (in shares) at Mar. 31, 2023   20,619        
Beginning balance at Mar. 31, 2023 $ 149,211 $ 210 (5,017) 436,907 (280,887) (2,002)
Stock issued upon option exercise and vesting of restricted stock units (in shares) 277 40        
Stock issued upon option exercise and vesting of restricted and performance stock units $ 42 $ 0   42    
Stock Issued During Period, Value, Employee Stock Purchase Plan 237 $ 1   236    
Share based compensation 1,582     1,582    
Net loss (3,765)       (3,765)  
Other comprehensive loss (493)         (493)
Ending balance (in shares) at Jun. 30, 2023   20,705        
Ending balance at Jun. 30, 2023 146,814 $ 211 (5,017) 438,767 (284,652) (2,495)
Stock issued, ESPP (in shares)   46        
Beginning balance (in shares) at Dec. 31, 2023   24,998        
Beginning balance at Dec. 31, 2023 191,655 $ 254 (5,017) 487,973 (290,440) (1,115)
Stock issued upon option exercise and vesting of restricted stock units (in shares)   301        
Stock issued upon option exercise and vesting of restricted and performance stock units 176 $ 3   173    
Stock issued upon acquisition 4,494 5   4,489    
Share based compensation 1,902     1,902    
Treasury Stock, Retired, Cost Method, Amount 0 $ (4) 5,017   (5,013)  
Net loss (308)       (308)  
Other comprehensive loss (244)         (244)
Ending balance (in shares) at Mar. 31, 2024   25,749        
Ending balance at Mar. 31, 2024 197,675 $ 258 0 494,537 (295,761) (1,359)
Stock issued upon acquisition (in Shares)   450        
Beginning balance (in shares) at Dec. 31, 2023   24,998        
Beginning balance at Dec. 31, 2023 $ 191,655 $ 254 (5,017) 487,973 (290,440) (1,115)
Stock issued upon option exercise and vesting of restricted stock units (in shares) 35          
Net loss $ (4,668)          
Ending balance (in shares) at Jun. 30, 2024   25,918        
Ending balance at Jun. 30, 2024 195,531 $ 259 0 496,743 (300,121) (1,350)
Beginning balance (in shares) at Mar. 31, 2024   25,749        
Beginning balance at Mar. 31, 2024 $ 197,675 $ 258 0 494,537 (295,761) (1,359)
Stock issued upon option exercise and vesting of restricted stock units (in shares) 9 58        
Stock issued upon option exercise and vesting of restricted and performance stock units $ 63 $ 0   63    
Stock Issued During Period, Value, Employee Stock Purchase Plan 333 1   332    
Stock issued upon acquisition 323 $ 0   323    
Share based compensation 1,488     1,488    
Net loss (4,360)       (4,360)  
Other comprehensive loss 9         9
Ending balance (in shares) at Jun. 30, 2024   25,918        
Ending balance at Jun. 30, 2024 $ 195,531 $ 259 $ 0 $ 496,743 $ (300,121) $ (1,350)
Stock issued upon acquisition (in Shares)   50        
Stock issued, ESPP (in shares)   61